• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Venla
    / Unipharm

    Active Ingredient
    Venlafaxine (as HCl) 37.5 mg, 75 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    28 X 37.5 mg

    partial basket chart 59681 22241


    28 X 75 mg

    partial basket chart 59682 22242

    Related information


    Two tablets a day.
    See prescribing information for full details.




    Hypersensitivity to venlafaxine, pregnancy, lactation, concurrent use with MAOI’s, under 18 years of age.
    See prescribing information for full details.

    Special Precautions

    Patients with raised intraocular pressure or those at risk of acute narrow-angle glaucoma should be monitored. Close supervision of high-risk patients should accompany initial drug therapy.

    Side Effects

    Insomnia, nervousness, weight loss, especially in underweight depressed patients. Inappropriate antidiuretic hormone secretion may occur in patients who are volume-depleted, elderly, or taking diuretics. Impaired platelet aggregation may result from platelet serotonin depletion. Increase in heart rate of 8.5 beats per minute, asthenia, vasodilatation, hypertension, nausea, constipation, anorexia, vomiting, flatulence, weight loss, dizziness, somnolence, insomnia, dry mouth, nervousness, abnormal dreams, tremor.

    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel